Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,584,000 | 2,078,000 | 980,000 | 4,128,000 | 3,000,000 |
| Depreciation Amortization | 593,000 | 401,000 | 199,000 | 897,000 | 697,000 |
| Accounts receivable | 95,000 | 120,000 | 167,000 | 681,000 | 654,000 |
| Accounts payable and accrued liabilities | -1,000 | -217,000 | -612,000 | -426,000 | 227,000 |
| Other Working Capital | 178,000 | -308,000 | -661,000 | 692,000 | 860,000 |
| Other Operating Activity | 678,000 | 267,000 | 551,000 | 295,000 | -416,000 |
| Operating Cash Flow | $4,127,000 | $2,341,000 | $624,000 | $6,267,000 | $5,022,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -459,000 | -279,000 | -137,000 | -491,000 | -340,000 |
| Net Acquisitions | -572,000 | -17,000 | N/A | -405,000 | -358,000 |
| Purchase Of Investment | -1,169,000 | -1,160,000 | -660,000 | -930,000 | -631,000 |
| Sale Of Investment | 1,460,000 | 300,000 | 0 | 2,705,000 | 2,085,000 |
| Other Investing Activity | -2,700,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,440,000 | $-1,156,000 | $-797,000 | $879,000 | $756,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -112,000 | -162,000 | -410,000 | -601,000 | -603,000 |
| Common Stock Issued | 164,000 | 127,000 | 85,000 | 347,000 | 244,000 |
| Common Stock Repurchased | -352,000 | -353,000 | -329,000 | -320,000 | -119,000 |
| Dividend Paid | -1,987,000 | -1,314,000 | -641,000 | -2,555,000 | -1,914,000 |
| Other Financing Activity | -124,000 | 10,000 | 18,000 | -313,000 | -303,000 |
| Financing Cash Flow | $-2,411,000 | $-1,692,000 | $-1,277,000 | $-3,442,000 | $-2,695,000 |
| Exchange Rate Effect | -152,000 | -2,000 | -5,000 | -10,000 | -9,000 |
| Beginning Cash Position | 9,595,000 | 9,595,000 | 9,595,000 | 5,901,000 | 5,901,000 |
| End Cash Position | 7,719,000 | 9,086,000 | 8,140,000 | 9,595,000 | 8,975,000 |
| Net Cash Flow | $-1,876,000 | $-509,000 | $-1,455,000 | $3,694,000 | $3,074,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,127,000 | 2,341,000 | 624,000 | 6,267,000 | 5,022,000 |
| Capital Expenditure | -459,000 | -279,000 | -137,000 | -491,000 | -340,000 |
| Free Cash Flow | 3,668,000 | 2,062,000 | 487,000 | 5,776,000 | 4,682,000 |